Patients who require chemotherapy treatment during radiation may also benefit from proton therapy because side effects can be reduced. How Does Proton Beam Therapy Work? During proton beam therapy, a ...

AIIMS head of the radiation oncology department, Dr Anil Kumar Goel, said that worldwide experiments say that proton beam therapy is proven to be the preferred method of treatment for many types ...

The V-650 is a double-beam spectrophotometer with a photomultiplier tube (PMT) detector. The high sensitivity of the PMT enables accurate measurements of low (and high) concentration samples.

said that the U.S. FDA cleared the investigational new drug application for BEAM-302 for the treatment of alpha-1 antitrypsin deficiency (AATD), a genetic condition causing lung and liver disease.

Rightsholders with EU-based operations should evaluate their supply chains and hedge against new vulnerabilities, say Michael Washbrook and Justyna Ostrowska-Krupa of Taylor Wessing.

Baird analyst Jonathan Komp upgraded the rating for Wolverine World Wide from Neutral to Outperform. Wolverine World Wide ...

and treatment response prediction. When integrated into radiomic workflows, DECT-derived features could complement traditional texture analysis. Additionally, DECT may aid in overcoming some ...

“The FDA’s clearance of our IND for BEAM-302 is a significant step toward advancing the development of this potential breakthrough treatment for patients living with AATD in the U.S.,” said ...

The V-660 is a double-beam spectrophotometer utilizing a double monochromator and a photomultiplier tube detector. The use of a double monochromator provides high resolution with extremely low ...

uniQure N.V. announced that the U.S. FDA has granted ... emphasizing its potential to significantly improve treatment for Huntington’s disease. Additional regulatory updates on the Biologics ...